[Ip-health] Report of Rectal Artesunate Meeting, 19 February 2016

Jaya Banerji banerjij at mmv.org
Wed May 25 02:16:05 PDT 2016

Dear colleagues,

On 19 February 2016, stakeholders from 13 organizations* spanning the field of malaria prevention and control, seven malaria-endemic countries in Africa (Democratic Republic of Congo, Burkina Faso, Malawi, Central African Republic, Kenya, Uganda and Zambia) and the WHO came together to discuss experiences, challenges and overcoming obstacles relating to the implementation of rectal artesunate (RAS) as a pre-referral intervention for the management of severe malaria in children. The meeting was co-convened in Nairobi, Kenya by Medicines for Malaria Venture (MMV), the US President's Malaria Initiative (PMI), UNICEF and Médecins Sans Frontières (MSF).

A report of the RAS Stakeholder Meeting is available in English and French at http://www.mmv.org/newsroom/publications/rectal-artesunate-stakeholders-meeting-report. It summarises the key issues relating to the adoption and implementation of RAS in malaria-affected regions and outlines recommended actions to speed up access to this life saving medicine.

* CHAI, CDC, IFRC, Malaria Consortium, MMV, MSF, PFSCM i+ solutions, PSI, Save the Children, UNICEF, UNITAID, USAID, US-PMI.

Jaya Banerji MPH | Medicines for Malaria Venture
Director Communications and Advocacy
T: +41 22 555 0327
M: +41 79 707 71 81

Defeating Malaria Together | www.mmv.org<http://www.mmv.org/>

This email and any attachments may contain confidential information. If you are not the intended recipient, please delete the email and any attachments and notify the sender immediately.

More information about the Ip-health mailing list